ECTE is a beauty of a chart!!! Check out the increased volume and the nice pincher to boot. This one is headed to the 50 ma, imo!!!
Plus, I believe they are presenting in a conference is a couple of weeks, hopefully we'll hear some good things from that!!!
Echo Therapeutics, Inc. (Nasdaq: ECTE), a company developing its needle-free Symphony® tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system, is pleased to announce that its clinical study was selected for poster presentation at the Society of Critical Care Medicine's 42nd Critical Care Congress which will be held January 19-23, 2013